KOBAYASHI SAROU

Profiles

Profiles

• 氏名

  KOBAYASHI SAROU

Affiliation

• Department of Neurology

Research achievements

Published Papers

Original paper
• Real-world achievement of higher standards for migraine prevention with CGRP monoclonal antibodies., Suzuki Keisuke;Suzuki Shiho;Kobayashi Saro;Shioda Mukuto;Fujita Hiroaki;Haruyama Yasuo;Hida Ryotaro;Hirata Koichi, Cephalalgia : an international journal of headache, 46(6), 3331024261453284, 01 Jun. 2026

  DOIPermalink
• Interictal thermal pain hypersensitivity and central sensitization in migraine patients: a case-control study using quantitative sensory testing., Suzuki Keisuke;Suzuki Shiho;Haruyama Yasuo;Shioda Mukuto;Kobayashi Saro;Hida Ryotaro;Hirata Koichi, Head & face medicine, 20 Mar. 2026

  DOIPermalink
• A Real-World Study of CGRP Monoclonal Antibodies for Migraine: Long-Term Effectiveness and Treatment Adherence., Suzuki Keisuke;Suzuki Shiho;Kobayashi Saro;Shioda Mukuto;Fujita Hiroaki;Haruyama Yasuo;Hirata Koichi, European journal of neurology, 33(3), e70562, Mar. 2026

  DOIPermalink
• A real-world study of the efficacy and tolerability of fremanezumab in migraine patients with a median follow-up of 14 months., Suzuki Shiho;Suzuki Keisuke;Haruyama Yasuo;Fujita Hiroaki;Shiina Tomohiko;Kobayashi Saro;Shioda Mukuto;Hida Ryotaro;Hirata Koichi, Neurological research and practice, 7(1), 37, 03 Jun. 2025

  DOIPermalink
• The effect of calcitonin gene-related peptide monoclonal antibodies on restless legs syndrome in patients with migraine., Suzuki Keisuke;Suzuki Shiho;Fujita Hiroaki;Kobayashi Saro;Shioda Mukuto;Hida Ryotaro;Hirata Koichi, The journal of headache and pain, 26(1), 36, 19 Feb. 2025

  DOIPermalink
• Usefulness of "AcT ratio" in diagnosis of internal carotid artery stenosis: a multicenter, retrospective, observational study., Tsukui Daisuke;Takekawa Hidehiro;Saito Kozue;Okabe Ryuta;Tanaka Akito;Kobayasi Saro;Igarasi Haruki;Suzuki Keisuke;Hamaguchi Hirotoshi, Journal of medical ultrasonics (2001), 06 Apr. 2024

  DOIPermalink
• Real-world effectiveness of erenumab in Japanese patients with migraine., Suzuki Keisuke;Suzuki Shiho;Shiina Tomohiko;Haruyama Yasuo;Kobayashi Saro;Shioda Mukuto;Hirata Koichi, Heliyon, 10(4), e26568, 17 Feb. 2024

  DOIPermalink
• 2(1), 57-64, 2023

  Permalink
• Plasma prostaglandin D2 synthase levels in sleep and neurological diseases., Suzuki Keisuke;Suzuki Shiho;Ishii Yuko;Okamura Madoka;Matsubara Takeo;Fujita Hiroaki;Nozawa Narihiro;Kobayashi Saro;Hirata Koichi, Journal of the neurological sciences, 411, 116692, 15 Apr. 2020

  DOIPermalink
• Suitable methods of measuring acceleration time in the diagnosis of internal carotid artery stenosis., Iizuka Kentaro;Takekawa Hidehiro;Iwasaki Akio;Igarashi Haruki;Suzuki Keisuke;Kobayashi Saro;Tsukui Daisuke;Hirata Koichi, Journal of medical ultrasonics (2001), 47(2), 327-333, Apr. 2020

  DOIPermalink

Review paper
• Managing sleep issues in Parkinson's disease: an up-to-date review., Suzuki Keisuke;Fujita Hiroaki;Kobayashi Saro, Expert review of neurotherapeutics, 25(2), 211-226, 10 Jan. 2025

  DOI
• Ultrasound diagnosis of carotid artery stenosis and occlusion., Takekawa Hidehiro;Tsukui Daisuke;Kobayasi Saro;Suzuki Keisuke;Hamaguchi Hirotoshi, Journal of medical ultrasonics (2001), 29 Sep. 2022

  DOIPermalink
• Point-of-care ultrasound for stroke patients in the emergency room., Takekawa Hidehiro;Tsukui Daisuke;Kobayasi Saro;Suzuki Keisuke;Hamaguchi Hirotoshi, Journal of medical ultrasonics (2001), 03 Feb. 2022

  DOIPermalink
• Central Sensitization in Migraine: A Narrative Review., Suzuki Keisuke;Suzuki Shiho;Shiina Tomohiko;Kobayashi Saro;Hirata Koichi, Journal of pain research, 15, 2673-2682, 2022

  DOIPermalink
• 52(3), 523-526, Feb. 2026

  Permalink
• 52(3), 533-535, Feb. 2026

  Permalink
• 294(5), 352-356, Aug. 2025

  Permalink
• 101(5), 611-617, Nov. 2024

  Permalink
• 51(4), 159-172, Jul. 2024

  Permalink
• 133(6), 1267-1270, Jun. 2024

  Permalink
• 98(3), 311-317, Mar. 2023

  Permalink
• 63(11), 2271-2276, Aug. 2021

  Permalink
• 127(6), 1195-1199, Jun. 2021

  Permalink
• 78(5), 778-785, May 2020

  Permalink
• 5(2), 77-81, Sep. 2018

  Permalink

Case report
• Zilucoplan is effective for ravulizumab-refractory generalized myasthenia gravis with the C5 p.Arg885His variant: a case report., Itagaki Yuya;Iguchi Masahiro;Hattori Kasumi;Akanuma Haruna;Koizumi Daisuke;Kobayashi Saro;Matsuda Nozomu;Kanai Kazuaki, Neuromuscular disorders : NMD, 61, 106386, 24 Feb. 2026

  DOIPermalink
• Can calcitonin gene-related peptide monoclonal antibody improve migraine and restless legs syndrome?, Suzuki Shiho;Suzuki Keisuke;Shiina Tomohiko;Kobayashi Saro;Hirata Koichi, Journal of the neurological sciences, 443, 120462, 20 Oct. 2022

  DOIPermalink
• Does good sleep reduce early-morning off periods in patients with Parkinson's disease?, Suzuki Keisuke;Fujita Hiroaki;Okamura Madoka;Kobayashi Saro;Hirata Koichi, Sleep, 43(8), 2020

  DOIPermalink
• 39(4), 727-730, Jul. 2022

  Permalink
• 34(2), 30-35, Jun. 2022

  Permalink
• 72(8), 0901-0905, Aug. 2020

  Permalink

Other
• Switching from calcitonin gene-related peptide monoclonal antibody monthly to fremanezumab quarterly based on the patient's preferred dosing schedule., Suzuki Shiho;Suzuki Keisuke;Shiina Tomohiko;Kobayashi Saro;Shioda Mukuto;Hirata Koichi, Journal of the neurological sciences, 455, 122786, 13 Nov. 2023

  DOIPermalink
• Possible role of neutrophils in astrocyte injury in neuromyelitis optica spectrum disorder., Kobayashi Saro;Kokubun Norito;Aoki Reika;Hamaguchi Mai;Matsuda Hadzki;Suzuki Keisuke, Journal of the neurological sciences, 438, 120293, 23 May 2022

  DOIPermalink

Educational activity

FD活動

• 2021